Business / Biotech

San Diego Startup's 'Molecular Glue' Makes Cancer Self-Destruct; Big Pharma Bets Billions

San Diego-based biotech company Neomorph has begun its first clinical trial for NEO-811, a 'molecular glue' designed to make cancer cells self-destruct. This innovative approach has garnered significant attention and billions of dollars in...